Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
F Ogushi, … , S D Straus, R G Crystal
F Ogushi, … , S D Straus, R G Crystal
Published November 1, 1987
Citation Information: J Clin Invest. 1987;80(5):1366-1374. https://doi.org/10.1172/JCI113214.
View: Text | PDF
Research Article Article has an altmetric score of 15

Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.

  • Text
  • PDF
Abstract

Alpha 1-antitrypsin (alpha 1AT) deficiency resulting from homozygous inheritance of the Z-type alpha 1AT gene is associated with serum alpha 1AT levels of less than 50 mg/dl and the development of emphysema in the third to fourth decades. Despite the overwhelming evidence that the emphysema of PiZZ individuals develops because of a "deficiency" of alpha 1AT and hence an insufficient antineutrophil elastase defense of the lung, epidemiologic evidence has shown that levels of alpha 1AT of only 80 mg/dl protect the lung from an increased risk of emphysema. With this background, we hypothesized that homozygous inheritance of the Z-type may confer an added risk beyond a simple deficiency of alpha 1AT by virtue of an inability of the Z-type alpha 1AT molecule to inhibit neutrophil elastase as effectively as the common M1-type molecule. To evaluate this hypothesis, the functional status of alpha 1AT from PiZZ individuals (n = 10) was compared with that of alpha 1AT from PiM1M1 individuals (n = 7) for its ability to inhibit neutrophil elastase (percent inhibition) as well as its association rate constant for neutrophil elastase (K association). Plasma alpha 1AT concentration, measured by radial immunodiffusion, was 34 +/- 1 mg/dl in PiZZ patients vs. 237 +/- 14 mg/dl for PiM1M1 plasma, a sevenfold difference. When titrated against neutrophil elastase, the present inhibition of PiZZ plasma was significantly less than Pi M1M1 plasma (ZZ 78 +/- 1% vs. M1M1 95 +/- 1%, P less than 0.001) as was purified Z type alpha 1AT (ZZ, 63 +/- 2% vs. M1M1 86 +/- 2%, P less than 0.001). Sodium dodecyl sulfate (SDS) gel comparisons of the complexes formed with M1-type alpha 1AT and Z-type alpha 1AT with elastase demonstrated the Z alpha 1AT-elastase complexes were less stable than the M1 alpha 1AT-elastase complexes, thus releasing some of the enzyme to continue to function as a protease. Consistent with these observations, the K association of purified Z-type alpha 1AT for neutrophil elastase was lower than that of M1-type alpha 1AT (ZZ 4.5 +/- 0.3 X 10(6) M-1s-1 vs. M1M1 9.7 +/- 0.4 X 10(6) M-1s-1, P less than 0.001), suggesting that for the population of alpha 1AT molecules, the active Z-type molecules take more than twice as long as the active M1-type alpha 1AT to inhibit neutrophil elastase. Consequently, not only is there less alpha1AT in PiZZ individuals, but the population of Z-type alpha1AT molecules is less competent as an inhibitor of neutrophil elastase than M1-type alpha1AT molecules. This combination of defects suggests that PiZZ individuals have far less functional antielastase protection than suggested by the reduced concentrations of alpha1AT alone, further explaining their profound risk for development of emphysema.

Authors

F Ogushi, G A Fells, R C Hubbard, S D Straus, R G Crystal

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 Total
Citations: 1 3 3 5 6 6 4 3 3 3 8 7 7 6 6 5 5 4 2 2 6 4 1 2 2 3 5 6 3 4 5 3 2 1 5 8 6 5 160
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (160)

Title and authors Publication Year
Alpha-1 antitrypsin deficiency-associated liver disease: From understudied disorder to the poster child of genetic medicine
Fromme M, Klebingat F, Ellis P, Strnad P
Hepatology Communications 2025
Undiagnosed Alpha-1 Antitrypsin Deficiency and the Perpetuation of Lung Health Inequity.
McElvaney OJ, Hagstrom J, Foreman MG, McElvaney NG
American journal of respiratory and critical care medicine 2024
A novel in vitro cell model of the proteinase/antiproteinase balance observed in alpha-1 antitrypsin deficiency
Chen CH, Crisford H, Scott A, Sapey E, Stockley RA
Frontiers in pharmacology 2024
Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency
Feitosa PH, Castellano MV, da Costa CH, Cardoso AD, Pereira LF, Fernandes FL, Costa FM, Felisbino MB, de Oliveira AF, Jardim JR, Miravitlles M
Jornal Brasileiro de Pneumologia 2024
NAFLD and AATD Are Two Diseases with Unbalanced Lipid Metabolism: Similarities and Differences.
Perez-Luz S, Matamala N, Gomez-Mariano G, Janciauskiene S, Martínez-Delgado B
Biomedicines 2023
Genotypic Frequencies of Mutations Associated with Alpha-1 Antitrypsin Deficiency in Unrelated Bone Marrow Donors from the Murcia Region Donor Registry in the Southeast of Spain.
Cuenca I, Botella C, Moya-Quiles MR, Jimenez-Coll V, Galian JA, Martinez-Banaclocha H, Muro-Pérez M, Minguela A, Legaz I, Muro M
2023
Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency
McElvaney OJ, Cleary B, Fraughen DD, Kelly G, McElvaney OF, Murphy MP, Branagan P, Gunaratnam C, Carroll TP, Goss CH, McElvaney NG
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 2023
A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application
M OBrien, G Murray, D Gogoi, A Yusuf, C McCarthy, M Wormald, M Casey, C Gabillard-Lefort, N McElvaney, E Reeves
International journal of molecular sciences 2022
Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE).
Parsopoulou F, Loules G, Zamanakou M, Csuka D, Szilagyi A, Kompoti M, Porebski G, Psarros F, Magerl M, Valerieva A, Staevska M, Obtulowicz K, Maurer M, Speletas M, Farkas H, Germenis AE
2022
Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
Buck E, Presotto MA, Brock J, Schlamp K, Veith M, Herth FJ, Trudzinski FC
Respiratory Medicine Case Reports 2022
Human placental proteomics and exon variant studies link AAT/SERPINA1 with spontaneous preterm birth.
Tiensuu H, Haapalainen AM, Tissarinen P, Pasanen A, Määttä TA, Huusko JM, Ohlmeier S, Bergmann U, Ojaniemi M, Muglia LJ, Hallman M, Rämet M
BMC Medicine 2022
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews.
Miravitlles M, Herepath M, Priyendu A, Sharma S, Vilchez T, Vit O, Haensel M, Lepage V, Gens H, Greulich T
European respiratory review : an official journal of the European Respiratory Society 2022
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
OJ McElvaney, GF Curley, S Rose-John, NG McElvaney
The lancet. Respiratory medicine 2021
Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus
SS Park, RR Ortega, CW Agudelo, JP Perez, BP Gandara, I Garcia-Arcos, C McCarthy, P Geraghty
Medicina 2021
Protein Aggregation in the ER: Calm behind the Storm
H Li, S Sun
Cells 2021
Heterozygosity of the Alpha 1‐Antitrypsin Pi*Z Allele and Risk of Liver Disease
A Hakim, M Moll, D Qiao, J Liu, JA LaskySu, EK Silverman, S Vilarinho, ZG Jiang, BD Hobbs, MH Cho
Hepatology Communications 2021
Clinical Cases in Hepatology
NV Bergasa
2021
Improving Screening for Alpha-1 Antitrypsin Deficiency with Direct Testing in the Pulmonary Function Testing Laboratory
S Gurevich, A Daya, CD Silva, C Girard, F Rahaghi
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 2021
High-resolution ex vivo NMR spectroscopy of human Z α1-antitrypsin
AM Jagger, CA Waudby, JA Irving, J Christodoulou, DA Lomas
Nature Communications 2020
α 1 Antitrypsin therapy modulates the neutrophil membrane proteome and secretome
MP Murphy, T McEnery, K McQuillan, OF McElvaney, OJ McElvaney, S Landers, O Coleman, A Bussayajirapong, P Hawkins, M Henry, P Meleady, EP Reeves, NG McElvaney
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2020
Anti-cytokines as a Strategy in Alpha-1 Antitrypsin Deficiency
OF McElvaney, MP Murphy, EP Reeves, NG McElvaney
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 2020
Dépistage du déficit en alpha1-antitrypsine sur sang capillaire recueilli sur papier-filtre : bilan des 20 premiers mois
CC Cellier, C Narjoz, F Zerimech, MF Odou, P Joly, C Lombard, JF Mornex, M Balduyck
Revue des Maladies Respiratoires 2020
Clinical manifestations in patients with PI*MM Malton genotypes. A matter still unsolved in alpha‐1 antitrypsin deficiency
M Aiello, A Fantin, C Longo, I Ferrarotti, G Bertorelli, A Chetta
Respirology Case Reports 2020
Aggregation of M3 (E376D) variant of alpha1- antitrypsin
A Bashir, Y Hazari, D Pal, D Maity, S Bashir, LR Singh, NN Shah, KM Fazili
Scientific Reports 2020
Circulating Truncated Alpha-1 Antitrypsin Glycoprotein in Patient Plasma Retains Anti-Inflammatory Capacity
EP Reeves, DM Dunlea, K McQuillan, CA ODwyer, TP Carroll, R Saldova, PR Akepati, MR Wormald, OJ McElvaney, V Shutchaidat, M Henry, P Meleady, J Keenan, DC Liberti, DN Kotton, PM Rudd, AA Wilson, NG McElvaney
Journal of immunology (Baltimore, Md. : 1950) 2019
Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer
CP Nader, A Cidem, NM Verrills, AJ Ammit
Respiratory Research 2019
Lectin Complement Pathway in Emphysema
KA Serban, A Mikosz, C Strange, SM Janciauskiene, J Stolk, D Jonigk, RA Sandhaus, I Petrache
American journal of respiratory and critical care medicine 2019
A combined in silico and in vitro study on mouse Serpina1a antitrypsin-deficiency mutants
R Eggenschwiler, A Patronov, J Hegermann, M Fráguas-Eggenschwiler, G Wu, L Cortnumme, M Ochs, I Antes, T Cantz
Scientific Reports 2019
Portuguese consensus document for the management of alpha-1-antitrypsin deficiency
AP Lopes, MA Mineiro, F Costa, J Gomes, C Santos, C Antunes, D Maia, R Melo, M Canotilho, E Magalhães, I Vicente, C Valente, BG Gonçalves, B Conde, C Guimarães, C Sousa, J Amado, ME Brandão, M Sucena, MJ Oliveira, S Seixas, V Teixeira, L Telo
2018
Phospholipid transfer protein and alpha-1 antitrypsin regulate Hck kinase activity during neutrophil degranulation
P Ochieng, S Nath, R Macarulay, E Eden, A Dabo, M Campos, XC Jiang, RF Foronjy, P Geraghty
Scientific Reports 2018
Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency
E Giacopuzzi, M Laffranchi, R Berardelli, V Ravasio, I Ferrarotti, B Gooptu, G Borsani, A Fra
Human Mutation 2018
Paucimannose-Rich N -glycosylation of Spatiotemporally Regulated Human Neutrophil Elastase Modulates Its Immune Functions
I Loke, O Østergaard, NH Heegaard, NH Packer, M Thaysen-Andersen
Molecular & cellular proteomics : MCP 2017
Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions
YM Hazari, A Bashir, M Habib, S Bashir, H Habib, MA Qasim, NN Shah, E Haq, J Teckmane, KM Fazili
Mutation Research/Reviews in Mutation Research 2017
Paucimannose-Rich N -glycosylation of Spatiotemporally Regulated Human Neutrophil Elastase Modulates Its Immune Functions
I Loke, O Østergaard, NH Heegaard, NH Packer, M Thaysen-Andersen
Molecular & cellular proteomics : MCP 2017
Alpha-1 Antitrypsin and Lung Cell Apoptosis
Karina A Serban, Irina Petrache
Annals of the American Thoracic Society 2016
Molecular Mechanism of Z α1-Antitrypsin Deficiency
X Huang, Y Zheng, F Zhang, Z Wei, Y Wang, RW Carrell, RJ Read, GQ Chen, A Zhou
The Journal of biological chemistry 2016
Alpha-1 Antitrypsin
A Wanner, RA Sandhaus
2016
Scavenger receptor class B, type I-mediated uptake of A1AT by pulmonary endothelial cells
AD Lockett, DN Petrusca, MJ Justice, C Poirier, KA Serban, NI Rush, M Kamocka, D Predescu, S Predescu, I Petrache
American journal of physiology. Lung cellular and molecular physiology 2015
Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency
EE Cummings, LP OReilly, DE King, RM Silverman, MT Miedel, CJ Luke, DH Perlmutter, GA Silverman, SC Pak, R Aldabe
PloS one 2015
The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema
AN Franciosi, C McCarthy, NG McElvaney
Expert Review of Respiratory Medicine 2015
The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B 4 Neutrophil Signaling
CA ODwyer, ME OBrien, MR Wormald, MM White, N Banville, K Hurley, C McCarthy, NG McElvaney, EP Reeves
Journal of immunology (Baltimore, Md. : 1950) 2015
Discovery of an Inhibitor of Z-Alpha1 Antitrypsin Polymerization
V Berthelier, JB Harris, KN Estenson, J Baudry, P Carloni
PloS one 2015
Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles
LJ Donato, RM Karras, JA Katzmann, DL Murray, MR Snyder
Respiratory Research 2015
A single-chain variable fragment intrabody prevents intracellular polymerization of Z  1-antitrypsin while allowing its antiproteinase activity
A Ordonez, J Perez, L Tan, JA Dickens, N Motamedi-Shad, JA Irving, I Haq, U Ekeowa, SJ Marciniak, E Miranda, DA Lomas
The FASEB Journal 2015
Deficiency Mutations of α 1 -antitrypsin Differentially Affect Folding, Function and Polymerization
I Haq, JA Irving, AD Saleh, L Dron, GL Regan-Mochrie, N Motamedi-Shad, JR Hurst, B Gooptu, DA Lomas
American journal of respiratory cell and molecular biology 2015
The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote
NJ Sinden, F Koura, RA Stockley
BMC Pulmonary Medicine 2014
α-1-Antitrypsin variants and the proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease
NJ Sinden, MJ Baker, DJ Smith, JU Kreft, TR Dafforn, RA Stockley
American journal of physiology. Lung cellular and molecular physiology 2014
Le déficit en alpha-1-antitrypsine
M Bouchecareilh
médecine/sciences 2014
α 1 -Antitrypsin Activates Protein Phosphatase 2A to Counter Lung Inflammatory Responses
P Geraghty, E Eden, M Pillai, M Campos, NG McElvaney, RF Foronjy
American journal of respiratory and critical care medicine 2014
Oxidant-mediated Aggregation of Z α 1 -Antitrypsin in Pulmonary Epithelial Cells Amplifies Lung Inflammation
I Blanco
American journal of respiratory and critical care medicine 2014
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency
L Pini, L Tiberio, N Venkatesan, M Bezzi, L Corda, M Luisetti, I Ferrarotti, M Malerba, DA Lomas, S Janciauskiene, E Vizzardi, D Modina, L Schiaffonati, C Tantucci
Respiratory Research 2014
Phase I/II Study of Intrapleural Administration of a Serotype rh.10 Replication-Deficient Adeno-Associated Virus Gene Transfer Vector Expressing the Human α1-Antitrypsin cDNA to Individuals with α1-Antitrypsin Deficiency
MJ Chiuchiolo, SM Kaminsky, D Sondhi, D Mancenido, C Hollmann, RG Crystal
Human Gene Therapy Clinical Development 2014
Emery and Rimoin's Principles and Practice of Medical Genetics
DC Wallace, MT Lott, V Procaccio
Emery and Rimoin's Principles and Practice of Medical Genetics 2013
Recent advances in α-1-antitrypsin deficiency-related lung disease
JA Brebner, RA Stockley
Expert Review of Respiratory Medicine 2013
Identification and characterization of α 1 -antitrypsin in fibrin clots
S Talens, JJ Malfliet, PT van Hal, FW Leebeek, DC Rijken
Journal of Thrombosis and Haemostasis 2013
α-1-Antitrypsin deficiency: clinical variability, assessment, and treatment
RA Stockley, AM Turner
Trends in Molecular Medicine 2013
A Monoclonal Antibody (MCPR3-7) Interfering with the Activity of Proteinase 3 by an Allosteric Mechanism
LC Hinkofer, SA Seidel, B Korkmaz, F Silva, AM Hummel, D Braun, DE Jenne, U Specks
The Journal of biological chemistry 2013
α1-Antitrypsin Phenotypes and Associated Serum Protein Concentrations in a Large Clinical Population
JA Bornhorst, DN Greene, ER Ashwood, DG Grenache
Chest 2013
Diseases of the Liver in Children
KF Murray, S Horslen
2013
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Small Molecules That Target Protein Misfolding
LK Gavrin, RA Denny, E Saiah
Journal of Medicinal Chemistry 2012
Age related development of respiratory abnormalities in non-index α-1 antitrypsin deficient studies
J Holme, JA Stockley, RA Stockley
Respiratory Medicine 2012
Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency
M Bouchecareilh, DM Hutt, P Szajner, TR Flotte, WE Balch
The Journal of biological chemistry 2012
Conformational properties of the disease-causing Z variant of α1-antitrypsin revealed by theory and experiment
I Kass, AS Knaupp, SP Bottomley, AM Buckle
Biophysical Journal 2012
How the Serpin α 1 -Proteinase Inhibitor Folds
K Dolmer, PG Gettins
The Journal of biological chemistry 2012
Alpha-1 antitrypsin deficiency
E Kelly, CM Greene, TP Carroll, NG McElvaney, SJ O’Neill
Respiratory Medicine CME 2011
Structural Change in β-Sheet A of Z α1-Antitrypsin Is Responsible for Accelerated Polymerization and Disease
AS Knaupp, SP Bottomley
Journal of Molecular Biology 2011
Alpha-1 Antitrypsin Deficiency
DH Perlmutter
Schiff s Diseases of the Liver Schiff/Schiff s Diseases of the Liver 2011
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis
JA Dickens, DA Lomas
Drug design, development and therapy 2011
Schiff's Diseases of the Liver: Schiff/Schiff's Diseases of the Liver
H Malhi, GJ Gores
Schiff's Diseases of the Liver: Schiff/Schiff's Diseases of the Liver 2011
Alpha-1-Antitrypsin Deficiency in Early Childhood
A Topic, D Prokic, I Stankovic
Fetal & Pediatric Pathology 2011
Alpha-1 antitrypsin deficiency
E Kelly, CM Greene, TP Carroll, NG McElvaney, SJ O'Neill
Respiratory Medicine 2010
Protein Misfolding Diseases
P Chakrabarty, P Das, TE Golde
Protein Misfolding Diseases 2010
α;1-Antitrypsin Protease Inhibitor MZ Heterozygosity Is Associated With Airflow Obstruction in Two Large Cohorts
IC Sørheim, P Bakke, A Gulsvik, SG Pillai, A Johannessen, PI Gaarder, EJ Campbell, A Agustí, PM Calverley, CF Donner, BJ Make, SI Rennard, J Vestbo, EF Wouters, PD Paré, RD Levy, HO Coxson, DA Lomas, CP Hersh, EK Silverman
Chest 2010
Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies
AR Tonelli, ML Brantly
Therapeutic advances in respiratory disease 2010
Molecular Pathology of Liver Diseases
SP Monga
2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Molecular Basis of Pulmonary Disease
Farver CF, Zander DS
Molecular Pathology 2009
Expression, purification and characterization of recombinant Z α1-Antitrypsin—The most common cause of α1-Antitrypsin deficiency
V Levina, W Dai, AS Knaupp, D Kaiserman, MC Pearce, LD Cabrita, PI Bird, SP Bottomley
Protein Expression and Purification 2009
Molecular Pathology
WB Coleman, GJ Tsongalis
Molecular Pathology 2009
Basic Concepts of Molecular Pathology
TC Allen, PT Cagle
2009
Endotoxin receptor CD14 in PiZ α-1-antitrypsin deficiency individuals
CS Sandström, N Novoradovskaya, CM Cilio, E Piitulainen, T Sveger, S Janciauskiene
Respiratory Research 2008
Alpha-1 Antitrypsin Deficiency: Pathogenesis, Clinical Presentation, Diagnosis, and Treatment
T Köhnlein, T Welte
The American Journal of Medicine 2008
Deficiência de alfa-1 antitripsina: diagnóstico e tratamento
AA Camelier, DH Winter, JR Jardim, CE Barboza, A Cukier, M Miravitlles
Jornal Brasileiro de Pneumologia 2008
Molecular Pathology of Lung Diseases
DS Zander, HH Popper, J Jagirdar, AK Haque, PT Cagle, R Barrios
2008
Molecular diagnostics of α1-antitrypsin deficiency
MP Kaczor, M Sanak, A Szczeklik
Expert Opinion on Medical Diagnostics 2007
Molecular diagnostics of α 1 -antitrypsin deficiency
MP Kaczor, M Sanak, A Szczeklik
Expert Opinion on Medical Diagnostics 2007
Parker B. Francis lectureship. Antitrypsin deficiency, the serpinopathies, and chronic obstructive pulmonary disease
DA Lomas
Proceedings of the American Thoracic Society 2006
Diagnosis of α-1-Antitrypsin Deficiency: An Algorithm of Quantification, Genotyping, and Phenotyping
MR Snyder, JA Katzmann, ML Butz, P Yang, DB Dawson, KC Halling, WE Highsmith, SN Thibodeau
Clinical chemistry 2006
Polymers of Z α1-Antitrypsin Co-Localize with Neutrophils in Emphysematous Alveoli and Are Chemotactic in Vivo
R Mahadeva, C Atkinson, Z Li, S Stewart, S Janciauskiene, DG Kelley, J Parmar, R Pitman, SD Shapiro, DA Lomas
The American Journal of Pathology 2005
SP-A binds alpha1-antitrypsin in vitro and reduces the association rate constant for neutrophil elastase
M Gorrini, A Lupi, P Iadarola, CD Santos, P Rognoni, D Dalzoppo, N Carrabino, E Pozzi, A Baritussio, M Luisetti
Respiratory Research 2005
α1-antitrypsin deficiency
JK Stoller, LS Aboussouan
The Lancet 2005
Lung Biology in Health and Disease: Cellular and Molecular Mechanisms
E Sapey, R Stockley
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential 2005
Respiratory Genetics
K Tantisira, J Drazen
Respiratory Genetics 2005
Comparison of the properties of rare variants of α1-proteinase inhibitor expressed in COS-1 cells and assessment of their potential as risk factors in human disease
S Ray, TD Mickleborough, JL Brown
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2005
Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology
DA Lomas, H Parfrey
Thorax 2004
Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk
DL DeMeo, EK Silverman
Thorax 2004
Z α1-Antitrypsin Polymerizes in the Lung and Acts as a Neutrophil Chemoattractant
AT Mulgrew, CC Taggart, MW Lawless, CM Greene, ML Brantly, SJ O'Neill, NG McElvaney
Chest 2004
Augmentation Therapy for ??1-Antitrypsin Deficiency:
GS Juvelekian, JK Stoller
Drugs 2004
Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies
DC Crowther, D Belorgey, E Miranda, KJ Kinghorn, LK Sharp, DA Lomas
European Journal of Human Genetics 2003
Alpha-1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy
David Lomas
Journal of Clinical Investigation 2002
Polyethylene Glycol Conjugation at Cys 232 Prolongs the Half-Life of α 1 Proteinase Inhibitor
AM Cantin, DE Woods, D Cloutier, EK Dufour, R Leduc
American journal of respiratory cell and molecular biology 2002
The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation
A Elssner, C Vogelmeier
Transplant Infectious Disease 2001
Therapeutic Elastase Inhibition by Alpha-1-Antitrypsin Gene Transfer Limits Neointima Formation in Normal Rabbits
JM Waugh, J Li-Hawkins, E Yuksel, PN Cifra, PG Amabile, PR Hilfiker, RS Geske, MD Kuo, JW Thomas, MD Dake, SL Woo
Journal of Vascular and Interventional Radiology 2001
Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency
JA Burrows, LK Willis, DH Perlmutter
Proceedings of the National Academy of Sciences 2000
LIVER INJURY IN ALPHA1-ANTITRYPSIN DEFICIENCY
DH Perlmutter
Clinics in Liver Disease 2000
Glucosidase and Mannosidase Inhibitors Mediate Increased Secretion of Mutant α1 Antitrypsin Z
NY Marcus, DH Perlmutter
The Journal of biological chemistry 2000
Quantum proteolysis by neutrophils: implications for pulmonary emphysema in α1-antitrypsin deficiency
EJ Campbell, MA Campbell, SS Boukedes, CA Owen
Journal of Clinical Investigation 1999
Serine proteinase inhibitor therapy in ?1-antitrypsin inhibitor deficiency and cystic fibrosis
G D�ring
Pediatric Pulmonology 1999
Quantum proteolysis by neutrophils: implications for pulmonary emphysema in α1-antitrypsin deficiency
EJ Campbell, MA Campbell, SS Boukedes, CA Owen
Journal of Clinical Investigation 1999
Bronchiolitis Obliterans Syndrome after (Heart–)Lung Transplantation: Impaired Antiprotease Defense and Increased Oxidant Activity
J Hirsch, A Elssner, G Mazur, KL Maier, I Bittmann, J Behr, M Schwaiblmair, H Reichenspurner, H Fürst, J Briegel, C Vogelmeier
American journal of respiratory and critical care medicine 1999
Molecular Biology of the Lung
RA Stockley
1999
Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency
N Novoradovskaya, J Lee, ZX Yu, VJ Ferrans, M Brantly
Journal of Clinical Investigation 1998
A possible association of alpha1-antitrypsin deficiency with the periodontal condition in adults
SJ Fokkema, MF Timmerman, FA Weijden, GN Wolffe, HH Renggli
Journal of Clinical Periodontology 1998
Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema
R Mahadeva, DA Lomas
Thorax 1998
Thein VitroEffect of Lithocholic Acid on the Polymerization Properties of PiZ Alpha-1-Antitrypsin
MC Gerbod, S Janciauskiene, JO Jeppsson, S Eriksson
Archives of Biochemistry and Biophysics 1998
Chronic Obstructive Pulmonary Disease (COPD)
Robert M., NR Anthonisen
American journal of respiratory and critical care medicine 1998
Pulmonary Cell Biology
RJ Mason, RG Crystal
American journal of respiratory and critical care medicine 1998
Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors
DR Ralston, CB Marsh, MP Lowe, MD Wewers
Journal of Clinical Investigation 1997
The proteinase-antiproteinase theory of emphysema: A speculative analysis of recent advances into the pathogenesis of emphysema
KR KNIGHT, JG BURDON, L COOK, S BRENTON, M AYAD, ED JANUS
Respirology 1997
Molecular Basis, Clinical Consequences and Diagnosis of Alpha-1 Antitrypsin Deficiency
MR Norman, AP Mowat, DC Hutchison
Annals of Clinical Biochemistry 1997
Elastase inhibitory capacity of purified canine alpha-1-antitrypsin
M Vatne, M Andersson, E Sevelius, L Jönsson
Journal of Comparative Pathology 1996
Kinetic characterisation of ALPHA-1-Antitrypsin F as an inhibitor of human neutrophil elastase
L Cook, JG Burdon, S Brenton, KR Knight, ED Janus
Pathology 1996
Bioengineering: α1-Proteinase Inhibitor Site-Specific Mutagenesis
M Luisetti, J Travis
Chest 1996
Use of Secretory Leukoprotease Inhibitor to Augment Lung Antineutrophil Elastase Activity
C Vogelmeier, A Gillissen, R Buhl
Chest 1996
Alpha-1-antitrypsin PLowell: a normally functioning variant present in low concentration
L Cook, J Burdon, S Brenton, ED Janus, K Knight
Australian and New Zealand Journal of Medicine 1995
Conceptual advances in the pathogenesis and treatment of childhood metabolic liver disease
J Teckman, DH Perlmutter
Gastroenterology 1995
The Z type variation of human α1-antitrypsin causes a protein folding defect
MH Yu, KN Lee, J Kim
Nature Structural Biology 1995
α 1 -Antitrypsin Mmalton (Phe 52 -deleted) Forms Loop-Sheet Polymers in Vivo .: EVIDENCE FOR THE C SHEET MECHANISM OF POLYMERIZATION
DA Lomas, PR Elliott, SK Sidhar, RC Foreman, JT Finch, DW Cox, JC Whisstock, RW Carrell
The Journal of biological chemistry 1995
CLINICAL MANIFESTATIONS OF ALPHA1-ANTITRYPSIN DEFICIENCY
DH Perlmutter
Gastroenterology Clinics of North America 1995
Letters to the editor
M Erta?, C Ertekin, H Efendi, H Uysal, AA Eisen, RZ Kern, E Chroni, CP Panayiotopoulos, C I�tiguez, H Escobar, A Jimenez-Escrig, KL McKinley, Y Harati, Y Campos, J Esteban, A Cabello, J Arenas, NS Chu, CC Huang, YH Wei, I Ozaki, M Baba, M Ogawa, M Matsunaga, DM Simpson, M Tagliati, M Tanaka, M Bruyland, W Lissens, MD Waele, C Demanet, MT Palmisani, A Evoli, AP Batocchi, E Bartoccioni, P Tonali, EJ Fredericks, LE Bello, L Hagenfeldt, U D�ubeln, G Solders, L Kaijser, JF Jabre, P Mancias, JM Slopis, JW Yeakley, FJ Vriesendorp
Muscle & Nerve 1994
Alpha1-antitrypsin: molecular structure and the Pi system
G Massi, C Chiarelli
Acta Paediatrica 1994
Pathogenesis of liver disease in alpha1-antitrypsin deficiency
A Nemeth
Acta Paediatrica 1994
Vitamin E and liver damage in MZ heterozygous infants with alpha1-antitrypsin deficiency
K Pittschieler
Acta Paediatrica 1993
Pharmacokinetics of Recombinant Secretory Leukoprotease Inhibitor Aerosolized to Normals and Individuals with Cystic Fibrosis
NG McElvaney, B Doujaiji, MJ Moan, MR Burnham, MC Wu, RG Crystal
American journal of respiratory and critical care medicine 1993
Elevation of Plasma Truncated Elastase α1-Proteinase Inhibitor Complexes in Patients with Inflammatory Lung Diseases
J Fujita, H Nakamura, Y Yamagishi, Y Yamaji, T Shiotani, S Irino
Chest 1992
Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor
C Vogelmeier, RC Hubbard, GA Fells, HP Schnebli, RC Thompson, H Fritz, RG Crystal
Journal of Clinical Investigation 1991
Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages
RC Hubbard, G Fells, J Gadek, S Pacholok, J Humes, RG Crystal
Journal of Clinical Investigation 1991
The cellular basis for liver injury in α1-antitrypsin deficiency
DH Perlmutter
Hepatology 1991
Use of a Highly Purified α1-Antitrypsin Standard to Establish Ranges for the Common Normal and Deficient α1-Antitrypsin Phenotypes
ML Brantly, JT Wittes, CF Vogelmeier, RC Hubbard, GA Fells, RG Crystal
Chest 1991
Construction and expression of alpha 1-proteinase inhibitor mutants and the effects of these mutations on secretion of the variant inhibitors
AA McCracken, KB Kruse, J Valentine, C Roberts, TZ Yohannes, JL Brown
The Journal of biological chemistry 1991
Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy
RG Crystal
Journal of Clinical Investigation 1990
Strategies for aerosol therapy ofα 1-antitrypsin deficiency by the aerosol route
RC Hubbard, RG Crystal
Lung 1990
Biosynthesis and Secretion of M- and Z-Type α1-Proteinase Inhibitor by Human Monocytes. Effect of Inhibitors of Glycosylation and of Oligosaccharide Processing on Secretion and Function
V GROSS, DV BERG, J KREUZKAMP, U GANTER, J BAUER, G WÜRTEMBERGER, C SCHULZ-HUOTARI, H BEESER, W GEROK
Biological Chemistry Hoppe-Seyler 1990
Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele
DT Curiel, C Vogelmeier, RC Hubbard, LE Stier, RG Crystal
Molecular and cellular biology 1990
α1-Antitrypsin Wbethesda: Molecular basis of an unusual α1-antitrypsin deficiency variant
MD Holmes, ML Brantly, GA Fells, RG Crystal
Biochemical and Biophysical Research Communications 1990
Comparative properties of human α-1-proteinase inhibitor glycosylation variants
A Guzdek, J Potempa, A Dubin, J Travis
FEBS Letters 1990
Expression of PiM-and PiZ-mutated forms of the human alpha 1-antitrypsin gene in transfected monkey COS1 cells
ES Davis, N Harpaz, EM Johnson
The Journal of biological chemistry 1990
Accumulation of the insoluble PiZ variant of human alpha 1-antitrypsin within the hepatic endoplasmic reticulum does not elevate the steady-state level of grp78/BiP
KS Graham, A Le, RN Sifers
The Journal of biological chemistry 1990
Fate of aerosolized recombinant DNA-produced alpha 1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance
RC Hubbard, MA Casolaro, M Mitchell, SE Sellers, F Arabia, MA Matthay, RG Crystal
Proceedings of the National Academy of Sciences 1989
Characterization of the Sequence of the Normal Alpha-1-antitrypsin M3 Allele and Function of the M3 Protein
D Curiel, V Laubach, C Vogelmeier, L Wurts, RG Crystal
American journal of respiratory cell and molecular biology 1989
The Alpha1-antitrypsin Gene and Its Mutations
RG Crystal, ML Brantly, RC Hubbard, DT Curiel, DJ States, MD Holmes
Chest 1989
Molecular Basis of the Liver and Lung Disease Associated with the α1-Antitrypsin Deficiency Allele Mmalton
DT Curiel, MD Holmes, H Okayama, ML Brantly, C Vogelmeier, WD Travis, LE Stier, WH Perks, RG Crystal
The Journal of biological chemistry 1989
Disruption of the 290–342 salt bridge is not responsible for the secretory defect of the PiZ α1-antitrypsin variant
RN Sifers, CP Hardick, SL Woo
The Journal of biological chemistry 1989
A Pro → Leu substitution in codon 369 of the alpha-1-antitrypsin deficiency variant PI MHeerlen
MH Hofker, T Nukiwa, HM van Paassen, M Nelen, JA Kramps, EC Klasen, RR Frants, RG Crystal
Human Genetics 1989
Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity
J Kleniewski, V Donaldson
Journal of Experimental Medicine 1988
Characterization of the gene and protein of the common alpha 1-antitrypsin normal M2 allele
T Nukiwa, ML Brantly, F Ogushi, GA Fells, RG Crystal
The American Journal of Human Genetics 1988
Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency
RC Hubbard, RG Crystal
The American Journal of Medicine 1988
Molecular basis of alpha-1-antitrypsin deficiency
M Brantly, T Nukiwa, RG Crystal
The American Journal of Medicine 1988
Characterization of the gene and protein of the alpha 1-antitrypsin "deficiency" allele Mprocida
H Takahashi, T Nukiwa, K Satoh, F Ogushi, M Brantly, G Fells, L Stier, M Courtney, RG Crystal
The Journal of biological chemistry 1988

← Previous 1 2 3 … 6 7 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
Referenced in 3 patents
Referenced in 2 clinical guideline sources
60 readers on Mendeley
See more details